An open label, single centre, assessor blind pilot study comparing topical tacrolimus 0.1% and hydrocortisone ointment 1% in the treatment of flexural psoriasis
- Conditions
- flexural psoriasis
- Registration Number
- EUCTR2004-003835-30-GB
- Lead Sponsor
- Belfast City Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- 20
- Subjects with diagnosis of flexural psoriasis and aged 18 or above
- Subjects who demonstrate willingness to participate in the study and comply with its procedures by signing a written informed consent
- women of childbearing potential who are prepared to use an acceptable method of birth control during the study and have a negative urine pregnancy test prior to study entry.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
- Female subjects who are pregnant or breast feeding.
- Subjects who have received treatment for flexural psoriasis 2 weeks prior to study entry.
- Subjects currently receiving immunosuppressive drugs.
- Subjects who have had a previous reaction to tacrolimus or its constituents
- Patient is simultaneously participating in any other clinical trial
- any form of substance abuse, psychiatric disorder or condition which may invalidate communication with the investigator.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method